Evidence map›Paper›PMID 26189694›Full record

ReviewNature reviews. Neuroscience2015

Immune mediators in the brain and peripheral tissues in autism spectrum disorder.

Myka L Estes, A Kimberley McAllister

Abstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 282 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
282citing papers in PubMed, 7 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

282 citing papers in PubMed, 7 syntheses or guidelines pooled it, 504 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Article
  13. Review
  14. A Developmental Neuroimmune Cascade Model of Autism Spectrum Disorder.International journal of molecular sciences · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

222 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Myka L EstesCenter for Neuroscience, University of California, Davis, 1544 Newton Court, Davis, California 95618, USA.
A Kimberley McAllisterCenter for Neuroscience, University of California, Davis, 1544 Newton Court, Davis, California 95618, USA.
University of California, Davis · US

Funding

UC Davis Conte Center: Neuroimmune Mechanisms of Psychiatric DisordersP50MH106438 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARTER, CAMERON S. · 2015 to 2025
$26.1M
Immune Molecules in Early Postnatal Nervous System DevelopmentR01NS060125 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MCALLISTER, A KIMBERLEY · 2010 to 2019
$3.3M
INTERFERONS IN AUTOIMMUNE ASSOCIATED-AVOIDANCE LEARNINGF32MH010643 · NIMH · UNIVERSITY OF COLORADO DENVER · PI SCHROTT, LISA M · 1993 to 1995
–
NIMH NIH HHS P50 MH106438NIMH NIH HHS P50‑MH106438‑01NINDS NIH HHS R01 NS060125NINDS NIH HHS R01‑NS060125‑05
6 · The paper itself

Abstract

Increasing evidence points to a central role for immune dysregulation in autism spectrum disorder (ASD). Several ASD risk genes encode components of the immune system and many maternal immune system-related risk factors--including autoimmunity, infection and fetal reactive antibodies--are associated with ASD. In addition, there is evidence of ongoing immune dysregulation in individuals with ASD and in animal models of this disorder. Recently, several molecular signalling pathways--including pathways downstream of cytokines, the receptor MET, major histocompatibility complex class I molecules, microglia and complement factors--have been identified that link immune activation to ASD phenotypes. Together, these findings indicate that the immune system is a point of convergence for multiple ASD-related genetic and environmental risk factors.

Indexed as

AnimalsBrainChild Development Disorders, PervasiveHumansRisk Factors

Identifiers

PMID26189694
PMCPMC5650494
OpenAlexW1498791230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.